Home › Trial NCT07288073
TIL Therapy in cSCC and MCC
- Trial IDNCT07288073
- StatusRecruiting
- PhasePhase 2
- Study typeInterventional
- SponsorKaram Khaddour, MD, MS
- Enrollment14
- Start date2026-02-10
- ConditionsCutaneous Squamous Cell Carcinoma · Merkel Cell Carcinoma · Metastatic Cutaneous Squamous Cell Carcinoma · Skin Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.